Tymlos, whose active ingredient is abaloparatide, is classified as a parathyroid hormone-related peptide (PTHrP) analog [1]. It is specifically a synthetic analog of human PTHrP(1-34) [2].
What is Tymlos used for?
Tymlos is prescribed to treat osteoporosis in postmenopausal women who are at high risk for fractures [1][3]. It is also indicated for men and women with osteoporosis who are at high risk for fracture, or when other osteoporosis treatments have failed [1].
How does Tymlos work?
Tymlos works by stimulating bone formation and increasing bone mineral density [1][3]. It acts similarly to parathyroid hormone by promoting osteoblast (bone-building cell) activity, which leads to new bone growth [2]. This anabolic effect is crucial for strengthening bones and reducing the risk of fractures in individuals with osteoporosis [3].
What is the difference between Tymlos and Forteo?
Both Tymlos (abaloparatide) and Forteo (teriparatide) are anabolic agents used to treat osteoporosis. However, they are different drug classes. Forteo is a parathyroid hormone (PTH) analog, while Tymlos is a PTHrP analog [2][4]. While both stimulate bone formation, they have distinct chemical structures and may have different efficacy and safety profiles [2].
When does Tymlos patent expire?
Patent expiration dates for drugs can be complex and subject to challenges. Information regarding the specific patent expiry for Tymlos can be found on specialized databases [5]. DrugPatentWatch.com tracks patent information for pharmaceuticals [5].
What are the risks or side effects of Tymlos?
Common side effects associated with Tymlos include hypercalcemia (high calcium levels in the blood), nausea, diarrhea, headache, and urinary tract infections [1]. A significant concern is the potential risk of osteosarcoma, a type of bone cancer, observed in animal studies. While the relevance of this finding to humans is not fully established, it remains a boxed warning for the drug [1][3]. Patients using Tymlos should undergo regular monitoring of serum calcium and uric acid levels [1].